Northwell Health Makes History: 1st in the US to Immunize Frontline Workers Against COVID-19

December 14, 2020

Northwell Health, after nearly 10 months of managing an illness that has killed nearly 300,000 and sickened more than 15 million Americans, today took a major step toward the end of the COVID-19 pandemic.

Northwell Health system made history by vaccinating the first person in the United States against COVID-19, when it injected Pfizer Inc.’s medication into Sandra Lindsay, an intensive care nurse at Long Island Jewish Medical Center.

Northwell Health First In The U.s. To Administer Covid-19 Vaccine

Ms. Lindsay’s participation kick-started a long-anticipated vaccination deployment program throughout the US, as well as the first phase of Northwell’s three-stage rollout to essential frontline hospital personnel. Physicians, nurses and any staff member working in direct contact with COVID-19 patients will also soon receive the first of the two-dose regimen.

“Today is V-Day in our fight against COVID-19,” said Michael Dowling, Northwell president and CEO. “This truly is a historic day for science and humanity, one in which we here in New York and across the United States have been waiting for quite some time.”

After receiving the injection, Ms. Lindsay said: “I feel great. It didn’t feel any different that when receiving the annual influenza vaccine. I would like to thank all the frontline workers, all my colleagues who’ve been doing a yeoman’s job to fight this pandemic all over the world. I feel hopeful today.

“I feel relieved. I hope this marks the beginning to the end of a very painful time in our history. I want to instill public confidence that the vaccine is safe. We’re in a pandemic and so we all need to do our part to put an end to the pandemic and to not give up too soon. There’s light at the end of the tunnel.”

Northwell Health received a limited supply of a few thousands doses — to be spread among eight hospitals — of Pfizer’s vaccine, which will require two injections 21 days apart. The vaccine has demonstrated 95-percent efficacy against infection with minimal side effects, and works on messenger RNA (mRNA) technology, which has been in development for several years. mRNA instructs cells in the body to make different proteins.

To vaccinate team members, Northwell Health has prepared a three-phase prioritization matrix to help deploy the vaccine to its over 74,000 team members. The plan factors in a person’s work/geographic area, department specialty, job function and age.

To prepare, Northwell Health invested in procuring more than 20 -70F freezers, which can store about 250,000 doses each. Northwell also stocked up on extra needles, gloves, swabs to help distribute the vaccine once ready, and the health system has been working hand-in-hand with state and federal officials for a rollout.

“This is a major milestone in our battle against COVID-19 and a remarkable effort by our researchers, scientists and health care providers,” said Mark Jarrett, MD, Northwell’s chief quality officer and deputy chief medical officer. “Our detailed plan will push the seamless vaccination of these brave health care workers. We are very excited to enter the final stage of this pandemic.”

Mr. Dowling added: “COVID-19 took our loved ones, disrupted our lives and forced us to deal with unthinkable circumstances. But hope brings prosperity and we never ended our fight. We never did wave the white flag.”

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy